Evidence map›Paper›PMID 33015630›Full record

ReviewFunction (Oxford, England)2020

Making a Dent in Dent Disease.

Katherine E Shipman, Ora A Weisz

Open access · goldAbstract readReview
In one paragraph

Review in Function (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. 4-Phenylbutyric Acid Treatment Reduces Low-Molecular-Weight Proteinuria in aInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Emerging roles of proximal tubular endocytosis in renal fibrosis.Frontiers in cell and developmental biology · 2023
    Review
  5. Role of ion channels in the mechanism of proteinuria (Review).Experimental and therapeutic medicine · 2023
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Katherine E ShipmanRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
Ora A WeiszRenal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
University of Pittsburgh · US

Funding

Single Nephron and MetabolomicsP30DK079307 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JACKSON, EDWIN KERRY · 2008 to 2022
$13.4M
Endocytic Pathway Dysfunction in Dent DiseaseR01DK125049 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI WEISZ, ORA A · 2020 to 2024
$2.3M
Megalin Traffic in Dent DiseaseF31DK121394 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHIPMAN, KATHERINE E · 2019 to 2021
$93k
NIDDK NIH HHS F31 DK121394NIDDK NIH HHS P30 DK079307NIDDK NIH HHS R01 DK125049
6 · The paper itself

Abstract

Dent disease (DD) is a rare kidney disorder caused by mutations in the Cl

Indexed as

Dent DiseaseChloride ChannelsEndocytosisHumansKidney Tubules, ProximalProteinuriaChloride ChannelscubilinDent diseaseendocytosismegalinrecyclingtubular proteinuria

Identifiers

PMID33015630
PMCPMC7519470
OpenAlexW3084915035

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.